| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $20.9M | +37.4% | +93.0% |
| SG&A Expense | $3.6M | -10.3% | -24.3% |
| Operating Income | -$24.4M | -27.5% | -57.5% |
| Interest Expense | $400K | — | +0.0% |
| Net Income | -$23.3M | -32.2% | -69.4% |
| EPS (Basic) | -$1.90 | -31.9% | -65.2% |
| EPS (Diluted) | -$1.90 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $27.0M | +34.6% | +38.9% |
| Short-term Investments | $77.0M | -20.2% | -45.0% |
| Current Assets | $107.6M | -12.4% | -33.1% |
| Total Assets | $109.5M | -12.4% | -33.3% |
| Current Liabilities | $17.1M | +28.0% | +46.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$48.6M | — | — |
| Investing Cash Flow | $55.5M | — | — |
| Financing Cash Flow | $2.9M | — | — |
| -31.9% |
| -65.2% |
| $17.4M |
| +23.2% |
| +27.0% |
| Stockholders' Equity | $92.1M | -17.0% | -38.8% |